Synthesis and structure–activity relationships for some novel diflapolin derivatives with benzimidazole subunit

Abstract

A series of derivatives of the potent dual soluble epoxide hydrolase (sEH)/5-lipoxygenase-activating protein (FLAP) inhibitor diflapolin was designed, synthesised, and characterised. These novel compounds, which contain a benzimidazole subunit were evaluated for their inhibitory activity against sEH and FLAP. Molecular modelling tools were applied to analyse structure–activity relationships (SAR) on both targets and to predict solubility and gastrointestinal (GI) absorption. The most promising dual inhibitors of these series are 5a, 6b, and 6c.

Keywords

• Diflapolin
• benzimidazoles
• soluble epoxide hydrolase (sEH)
• 5-lipoxygenase activating protein (FLAP)
• solubility and GI absorption prediction